Carboquone: Indication, Dosage, Side Effect, Precaution

Generic Medicine Info Full Generic Medicine Info

Dosage/Direction for Use Action CIMS Class ATC Classification

This information is not country-specific. Please refer to the India prescribing information.

Full Generic Medicine Info

Dosage/Direction for Use

Oral
Chronic myeloid leukaemia
Adult: Initial doses for remission induction: 1-2 mg daily. Maintenance: 0.25-0.75 mg every other day or twice wkly; adjust dose to maintain WBC count between 8000 and 15000/mm³. Doses may vary depending on regimens.

Action

Carboquone, an alkylating agent, is used in the treatment of malignant neoplasms of the lung, stomach, ovary, lymphomas and in chronic myeloid leukaemia. It is usually administered by IV or intra-arterial route, or by mouth.

CIMS Class

Cytotoxic Chemotherapy

ATC Classification

L01AC03 - carboquone ; Belongs to the class of alkylating agents, ethylene imines. Used in the treatment of cancer.

Disclaimer: This information is independently developed by CIMS based on carboquone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2023 CIMS. All rights reserved. Powered by CIMSAsia.com